BIOMAT Database Logo BIOMAT Database Logo

[Josamycin: antibacterial activity against anaerobes (author's transl)]. 1978

K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki

UI MeSH Term Description Entries
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002509 Cephaloridine A cephalosporin antibiotic. Cefaloridine,Cephalomycine,Cephaloridin,Ceporin
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005673 Fusobacterium A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections. Sphaerophorus
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Antibacterial activity of lividomycin against anaerobes].
December 1972, The Japanese journal of antibiotics,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
June 1976, Antimicrobial agents and chemotherapy,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Fundamental studies of josamycin against Mycoplasma pneumoniae (author's transl)].
September 1981, The Japanese journal of antibiotics,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Josamycin and pediatric infections (author's transl)].
June 1981, Annales de pediatrie,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[In vitro activity of cefotaxime on anaerobes (author's transl)].
February 1981, La Nouvelle presse medicale,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Susceptibility testing of anaerobes (author's transl)].
December 1978, Immunitat und Infektion,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[The antibacterial activity of diphenhydramine (author's transl)].
October 1978, Wiener klinische Wochenschrift,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
Quinolone activity against anaerobes.
January 1999, Drugs,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Antibacterial activity of cefotaxime against main bacteria isolated from clinical samples (author's transl)].
March 1981, The Japanese journal of antibiotics,
K Watanabe, and I Watanabe, and T Ezaki, and S Kobata, and H Imamura, and K Ninomiya, and K Ueno, and S Suzuki
[Antibacterial and antimycotic activity of the amniotic fluid against selected germs (author's transl)].
March 1977, Geburtshilfe und Frauenheilkunde,
Copied contents to your clipboard!